- Home
- XCUR
XCUR
Exicure Inc.
as 04-18-2025 1:45pm EST
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 26.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.75 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.44 - $36.00 | Next Earning Date: | 06-16-2025 |
| Revenue: | $500,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Exicure Inc. News
XCUR Breaking Stock News: Dive into XCUR Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma
Business Wire
8 days ago
Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)
Business Wire
a month ago
Exicure, Inc. Reports Full Year 2024 Financial Results
Business Wire
a month ago
Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia
Business Wire
3 months ago
CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
Business Wire
4 months ago
Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
Business Wire
4 months ago
CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
Business Wire
5 months ago
Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results
Compare XCUR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XCUR Exicure Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.